Trial intelligence / Profile preview

Sevoflurane Doses for ECT Anesthesia Induction

NCT01905904Phase 4Completed

Sponsor
Inonu University
Start
Mar 2013
Primary completion
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of sevoflurane (2 arms), sponsored by Inonu University. Primary endpoint: Duration of seizure (EEG and EMG). Started Mar 2013; status: completed.

02

Drugs

sevoflurane

Beyond the preview

Go deeper on NCT01905904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01905904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call